You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Claims for Patent: 4,002,758


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,002,758
Title: Medicament which is utilizable in ophthalmology
Abstract:A method of treating ophthalmological disorders is disclosed. The method comprises the oral administration from one to four times a day of a composition comprising: A. from 200 to 1,000 mg of a compound selected from the group consisting of cystine and cysteine B. from 50 to 300 mg of pyridoxine in the form of a base or a salt.
Inventor(s): Bigou; Alphonse (Paris, FR)
Assignee: Societe B.F.B. (Champigny, FR)
Application Number:05/592,513
Patent Claims:1. A method of treating ophthalmological disorders of the cornea in which there is lysis of collagen by the action of collagenase which comprises the oral administration to a patient in need thereof from one to four times a day of a composition comprising:

a. from 200 to 1,000 mg of a compound selected from the group consisting of cystine and cysteine

b. from 50 to 300 mg of pyridoxine in the form of a base or a salt.

2. A method of treating ophthalmological disorders of the cornea in which there is lysis of collagen by the action of collagenase which comprises the oral administration to a patient in need thereof from one to four times a day of a composition comprising:

a. 500 mg of cystine

b. 100 mg of pyridoxine.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.